Risk-based approach for the transfer of quantitative methods: Bioanalytical applications

Journal of Chromatography A

Volumn 1189, Issue 1-2, 2008, Pages 32-41

  Rozet, E ^a   Dewe W ^b   Morello, R ^c   Chiap, P ^d   Lecomte, F ^a   Ziemons, E ^a   Boos, K S ^c   Boulanger, B ^e   Crommen, J ^a   Hubert, Ph ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UCB PHARMA   (Belgium)

Author keywords

Analytical method transfer; Bioanalysis; Catecholamines; N Methyl laudanosine; Risk; Tolerance interval; Total error

Indexed keywords

AMINES; ELECTROCHEMISTRY; EXTRACTION; LIQUID CHROMATOGRAPHY; PLASMAS;

ANALYTICAL METHOD TRANSFER; TOLERANCE INTERVAL; TOTAL ERROR;

RISK ASSESSMENT;

CATECHOLAMINE; LAUDANOSINE;

ANALYTIC METHOD; ARTICLE; ELECTROCHEMICAL DETECTION; FLUORESCENCE ANALYSIS; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; STATISTICAL ANALYSIS;

CATECHOLAMINES; CHROMATOGRAPHY, LIQUID; HUMANS; ISOQUINOLINES; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION;

EID: 41949089218     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2007.11.029     Document Type: Article

References (39)

1. Hubert Ph., N'guyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. J. Pharm. Biomed. Anal. 36 (2004) 579
2. Rozet E., Ceccato A., Hubert C., Ziemons E., Oprean R., Rudaz S., Boulanger B., and Hubert Ph. J. Chromatogr. A 1158 (2007) 111
3. International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva, 2005.
4. ISO 5725 parts 1-6, Accuracy (trueness and precision) of measurement methods and results, International Organization for Standardization (ISO), Geneva, 1994.
5. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, US Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Rockville, May 2001.
6. Analytical Procedure/Technology Transfer, International Society for Pharmaceutical Engineering (ISPE) Guideline, 2003, pp. 23-24.
7. Minois-Offroy F., Appriou Y., Brousset V., Chapuzet E., de Fontenay G., Dewé W., Dumas E., Ellie C., Galiay M., Lefebvre N., Mottu P., Quint M.P., and Schoeffter F. STP Pharma. Pratiques 12 (2002) 337
8. Kringle R., Khan-Malek R., Snikeris F., Munden P., Agut C., and Bauer M. Drug Inf. J. 35 (2001) 1271
9. Rodriguez S.A., Kubiak R., Mulcey M., Tamblyn T., and Tougas T. Am. Lab. 37 (2005) 9
10. Schepers U., and Wätzig H. J. Pharm. Biomed. Anal. 39 (2005) 310
11. Chambers D., Kelly G., Limentani G., Lister A., Lung R., and Warner E. Pharm. Technol. September (2005) 64-80
12. A.J. DeStefano, Issues in the Transfer of Methods to Analysts and Laboratories, AAPS Third Bioanalytical Workshop: Quantitative Bioanalytical Methods Validation and Implementation - Best Practices for Chromatographic and Ligand Binding Assays, Arlington, VA, May 1-3, 2006, http://www.aapspharmaceutica.com/meetings/meeting.asp?id=64.
13. Lukulay P.H. Considerations for a Successful Analytical Method Transfer for Pharmaceuticals, Institute of Validation Technology (IVT) Conferences on Method Validation. Dublin, Ireland, May 16-19 (2006)
14. Schepers U., and Wätzig H. J. Pharm. Biomed. Anal. 41 (2006) 290
15. Feng S., Liang Q., Kinser R.D., Newland K., and Guilbaud R. Anal. Bioanal. Chem. 385 (2006) 975
16. Vial J., Jardy A., Anger P., Brun A., and Menet J.M. J. Chromatogr. A 815 (1998) 173
17. Ramond B., Gaillandre A., Gibelin N., Michalski C., Nabet P., Niewiaski C., Poirault D., and Rigal H. STP Pharma. Pratiques 17 (2007) 67
18. Dewé W., Govaerts B., Boulanger B., Rozet E., Chiap P., and Hubert Ph. Chemom. Intell. Lab. Syst. 85 (2007) 262
19. Rozet E., Mertens B., Dewe W., Ceccato A., Govaerts B., Boulanger B., Chiap P., Streel B., Crommen J., and Hubert Ph. J. Pharm. Biomed. Anal. 42 (2006) 64
20. Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. STP Pharma. Pratiques 13 (2003) 101
21. Lee J.W., Devanarayan V., Barrett Y.C., Weiner R., Allinson J., Fountain S., Keller S., Weinryb I., Green M., Duan L., Rogers J.A., Millham R., O'Brian P.J., Sailstad J., Khan M., Ray C., and Wagner J.A. Pharm. Res. 23 (2006) 312
22. DeSilva B., Smith W., Weiner R., Kelley M., Smolec J., Lee B., Khan M., Tacey R., Hill H., and Celniker A. Pharm. Res. 20 (2003) 1885
23. B. Boulanger, W. Dewe, Ph. Hubert, B. Govaerts, C. Hammer, F. Moonen, Accuracy and Precision (Total error vs. 4/6/30), AAPS Third Bioanalytical Workshop: Quantitative Bioanalytical Methods Validation and Implementation - Best Practices for Chromatographic and Ligand Binding Assays, Arlington, VA, May 1-3, 2006, http://www.aapspharmaceutica.com/meetings/meeting.asp?id=64.
24. Boulanger B., Dewe W., Gilbert A., Govaerts B., and Maumy-Bertrand M. Chemom. Intell. Lab. Syst. 86 (2007) 198
25. Findlay J.W.A., Smith W.C., Lee J.W., Nordblom G.D., Das I., DeSilva B.S., Khan M.N., and Bowsher R.R. J. Pharm. Biomed. Anal. 21 (2000) 1249
26. Feinberg M., Boulanger B., Dewé W., and Hubert Ph. Anal. Bioanal. Chem. 380 (2004) 502
27. Hubert Ph., Lagorce P., Lallier M., Laparra M.C., Laurentie M., Nivet J.C., Chiap P., and Grandjean D. Anal. Chim. Acta 391 (1999) 135
28. Chiap P., Hubert Ph., Boulanger B., and Crommen J. Anal. Chim. Acta 391 (1999) 227
29. Rozet E., Wascotte V., Lecouturier N., Préat V., Dewé W., Boulanger B., and Hubert Ph. Anal. Chim. Acta 591 (2007) 239
30. International Conference on Harmonization (ICH): Quality Risk Management Q9, Geneva, 2005, http://www.emea.eu.int/Inspections/docs/ICHQ9Step4QRM.pdf.
31. Process Analytical Technology (PAT), Initiative, US Food and Drugs Administration, Rockville, MD, 2004, http://www.fda.gov/cder/OPS/PAT.htm.
32. Graulich A., Mercier F., Scuvée-Moreau J., Seutin V., and Liégeois J.-F. Bioorg. Med. Chem. 13 (2005) 1201
33. Rozet E., Morello R., Lecomte F., Martin G.B., Chiap P., Crommen J., Boos K.S., and Hubert Ph. J. Chromatogr. B 844 (2006) 251
34. Morello R., Boos K.-S., and Seidel D. GIT Lab. J. Eur. 6 (2004) 30
35. Hartmann C., Massart D.L., and McDowall R.D. J. Pharm. Biomed. Anal. 12 (1994) 1337
36. Boulanger B., Chiap P., Dewe W., Crommen J., and Hubert Ph. J. Pharm. Biomed. Anal. 32 (2003) 753
37. Burdick R.K., and Graybill F.A. Confidence Intervals on Variance Components (1992), Marcel Dekker, New York
38. Hubert Ph., N'guyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., and Rozet E. J. Pharm. Biomed. Anal. 45 (2007) 82
39. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., Shah V.P., Skelly J.P., Swann P.G., and Weiner R. AAPS J. 9 (2007) E30. http://www.aapsj.org